COSMIC-021 Trial Shows Efficacy and Tolerability in mCRPC

(1:48)

COSMIC-021: Cabozantinib + atezolizumab gives clinical activity in inoperable metastatic UC

(2:22)

Lobular Cancer Genetics and Contralateral Risk | Lobular Breast Cancer Event 2023

(33:30)

GRACEcast-021_Lung-Cancer_Stage IIIA Management Options

(9:36)

MITOPE: RSO-021, a novel PRX3 inhibitor, in mesothelioma or other pleural cancers

(3:54)

Dr. Agarwal on Cohort 6 Results ​From the COSMIC-021 Trial in mCRPC

(2:5)

Dr. Agarwal on the Progression of the COSMIC-021 Trial in mCRPC

(50)

GRACEcastUC-021_Lung_What is MyCancerGenome.org?

(2:28)

Dr. Pal on Cohort Findings of COSMIC-021 Trial in mCRPC

(1:22)

Researcher comment: The COSMIC-021 mCRPC cohort | Neeraj Agarwal

(3:21)

COSMIC-021, Cabozantinib in Combination with Atezolizumab

(2:21)

Nikki Lytle - Where Cures Begin - Episode 021

(20:3)

Dr. Agarwal on the COSMIC-021 Trial Design in Castration-Resistant Prostate Cancer

(2:13)

Dr. Rudin on Caveats of the KEYNOTE-021 in Patients With NSCLC

(54)

Oriental Medical Digest Ep021 Skin cancer 피부암

(8:2)

Simplify Cancer Podcast E021 - Laugh Your Way To A Better Life Despite Cancer

(21:15)

COSMIC-021 cohorts continue to show encouraging cabozantinib–atezolizumab UC activity | Sumanta Pal

(2:11)

APCCA2019_021_Session 3B: Living Well with Cancer – A Personalized and Need-based Cancer Care

(18:28)

ACLR 021: How to Cure Children’s Cancer with Researcher Andy Woods

(1:37:10)

An Analysis of SARC021

(1:11)